Study links metal levels in urine to childhood obesity risk
Researchers from the Granada Biosanitary Research Institute and the University of Granada have revealed positive and negative associations between exposure to a combination of different metals and overweight and obesity in ...
Dec 10, 2024
0
0
Are weight loss drugs like Ozempic, Wegovy safe for kids?
Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional—and often ineffective—advice to "eat less and exercise more."
Dec 9, 2024
0
0
Who gets obesity drugs covered by insurance? In North Carolina, it helps if you're on Medicaid
After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets don't work.
Dec 9, 2024
0
0
Weight loss brings Americans big health care savings
The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs' cost should be covered by Medicare, Medicaid and private insurers.
Dec 5, 2024
0
0
Zepbound bests Wegovy for weight loss in new trial
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.
Dec 4, 2024
0
1
Paternal weight associated with baby's size at birth, study finds
A study in Brazil involving 89 father-mother-baby triads points to an association between paternal overweight and newborn birth weight: the higher the father's body mass index (BMI, weight divided by height squared), the ...
Dec 4, 2024
0
0
About one-third eligible for weight loss drugs meet trial exclusion criteria
About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 (GLP-1) receptor agonists and GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists ...
Dec 3, 2024
0
0
What makes oatmeal the ideal breakfast for heart health and weight loss?
Oatmeal is a nutritious, inexpensive and versatile way to incorporate whole grains into the diet. Oats made history when they became the first food with a Food and Drug Administration health claim label in 1997. This claim ...
Dec 3, 2024
0
3
Obesity treatment in a natural, food-grade microcapsule has no unpleasant side effects
As obesity rates continue to rise, many are turning to prescription medicines like Ozempic for weight loss. But with significant side effects, accessibility and cost issues, alternatives are needed.
Dec 2, 2024
0
0
Philly's soda tax had an impact on health in the city, research finds
When University of Pennsylvania researcher Christina Roberto set out to study Philadelphia's soda tax, she wasn't convinced she would find much health impact.
Nov 29, 2024
0
13
Why some people don't lose weight with Wegovy
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% of their body weight. But the drugs don't work for everyone.
Nov 29, 2024
0
0
Team discovers that a key mechanism in fat cells protects the body against energetic excess
A research team has identified an essential mechanism in fat cells (adipocytes) that enables them to enlarge safely to store energy. This process avoids tissue damage and protects the body from the toxic effects of accumulating ...
Nov 28, 2024
0
8
Higher sweet beverage tax shows null result in lowing Philadelphia youth obesity
Children's Hospital of Philadelphia, the University of Pennsylvania, Harvard Medical School and the Harvard T.H. Chan School of Public Health found no significant changes in pediatric weight outcomes two years after implementing ...
Research shows death rates linked to obesity-related heart disease are up, especially among men
The rate of deaths from ischemic heart disease related to obesity nearly tripled in the U.S. over a two-decade span, according to new research. The rate for men more than tripled.
Nov 27, 2024
0
0
208 million Americans are classified as obese or overweight, according to new study on 132 data sources
Nearly half of adolescents and three-quarters of adults in the U.S. were classified as being clinically overweight or obese in 2021. The rates have more than doubled compared with 1990.
Nov 27, 2024
0
0
The role of social media in the stigmatization of persons living with obesity
Through an analysis of posts on Twitter (now rebranded X) relating to obesity published between April 2019 and December 2022, a study conducted by the Geneva University Hospitals (HUG) and the University of Geneva (UNIGE) ...
Nov 27, 2024
0
0
Biden will move to have Medicare, Medicaid cover GLP-1 weight-loss meds
The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid.
Nov 26, 2024
0
0
Popular diabetes and obesity drugs also protect kidneys, study shows
The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes. The findings ...
Nov 25, 2024
0
71
Taking a GLP-1 medication? Expert offers tips for holiday eating
So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays near you worry about how to handle gatherings where decadent food will be served in abundance.
Nov 25, 2024
0
0
Study examines California's legislative efforts on obesity
A recent multi-campus study, co-led by public health researchers from UC Irvine and UC Merced, published in the journal BMC Public Health is the first of its kind to examine California's legislative approaches to prevent ...
Nov 25, 2024
0
0
Metabolic and bariatric surgery safe and effective for patients with severe obesity
A team of researchers led by Pennington Biomedical Research Center's Dr. Florina Corpodean has confirmed through a data analysis that metabolic and bariatric surgery is largely safe and effective for patients who are experiencing ...
Nov 21, 2024
0
0
New study tracks leptin pulse patterns, a potential clue to understanding obesity
Obesity has become a global epidemic, and the need for treatment and monitoring for people with obesity is growing. Researchers aiming to understand relevant biomarkers for the condition have fixed their gaze on leptin, a ...
Nov 20, 2024
0
0
Surprising patterns in infant growth after gestational diabetes exposure challenge current views on obesity risk
A new study led by researchers at The University of Texas at Austin and Harvard Medical School reveals surprising findings about how babies exposed to gestational diabetes mellitus (GDM) grow during their first year of life.
Nov 19, 2024
0
0